Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Current Deferred Revenue (2017 - 2020)

Cogent Biosciences (COGT) has 3 years of Current Deferred Revenue data on record, last reported at $312000.0 in Q2 2020.

  • For Q2 2020, Current Deferred Revenue fell 97.94% year-over-year to $312000.0; the TTM value through Jun 2020 reached $312000.0, down 97.94%, while the annual FY2019 figure was $1.3 million, 92.67% down from the prior year.
  • Current Deferred Revenue reached $312000.0 in Q2 2020 per COGT's latest filing, down from $841000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $20.4 million in Q2 2018 and bottomed at $312000.0 in Q2 2020.
  • Average Current Deferred Revenue over 3 years is $12.5 million, with a median of $16.0 million recorded in 2019.
  • Peak YoY movement for Current Deferred Revenue: fell 3.53% in 2019, then plummeted 97.94% in 2020.
  • A 3-year view of Current Deferred Revenue shows it stood at $17.9 million in 2018, then plummeted by 92.67% to $1.3 million in 2019, then crashed by 76.27% to $312000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $312000.0 in Q2 2020, $841000.0 in Q1 2020, and $1.3 million in Q4 2019.